Sign in
4

Changes in Ownership

FATE THERAPEUTICS INC Filed Acc 0001104659-23-069540

Options or other derivatives

  • Director acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Redmile Group, LLC Director 2023-06-06 Grant or award · Stock Option (Right to Buy) +40,000 40,000 I
Loading xslF345X04/tm2318137-2_4seq1.xml…